Literature DB >> 7557018

Oligonucleotide-mediated modulation of mammalian gene expression.

K J Scanlon1, Y Ohta, H Ishida, H Kijima, T Ohkawa, A Kaminski, J Tsai, G Horng, M Kashani-Sabet.   

Abstract

The notion that oligonucleotides can modulate gene-specific expression was established more than a decade ago. Recent advances in molecular genetics have broadened the armamentarium used to manipulate gene expression in biological systems including triplex DNA, antisense RNA/DNA, and ribozymes (catalytic RNA). These oligonucleotides demonstrated important early application to the elucidation of cellular signaling pathways. More recently, studies with these agents have probed their utility as potential therapeutic agents, especially in the realm of cancer. With the implementation of gene therapy in early clinical trials, oligonucleotide-mediated suppression of gene expression has emerged as an important strategy for gene therapy. This review will discuss the current knowledge in this field, focusing on the biology of triplex DNA, antisense oligonucleotides, and ribozymes.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7557018     DOI: 10.1096/fasebj.9.13.7557018

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  8 in total

1.  Generation of circular RNAs and trans-cleaving catalytic RNAs by rolling transcription of circular DNA oligonucleotides encoding hairpin ribozymes.

Authors:  A M Diegelman; E T Kool
Journal:  Nucleic Acids Res       Date:  1998-07-01       Impact factor: 16.971

Review 2.  Synthetic oligonucleotides: useful molecules? A review.

Authors:  A Calogero; G A Hospers; N H Mulder
Journal:  Pharm World Sci       Date:  1997-12

3.  Targeting of the HIV-1 long terminal repeat with chromomycin potentiates the inhibitory effects of a triplex-forming oligonucleotide on Sp1-DNA interactions and in vitro transcription.

Authors:  N Bianchi; C Rutigliano; M Passadore; M Tomassetti; L Pippo; C Mischiati; G Feriotto; R Gambari
Journal:  Biochem J       Date:  1997-09-15       Impact factor: 3.857

4.  Development of diabetes mellitus in aging transgenic mice following suppression of pancreatic homeoprotein IDX-1.

Authors:  M K Thomas; O N Devon; J H Lee; A Peter; D A Schlosser; M S Tenser; J F Habener
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

5.  Ribozyme as an approach for growth suppression of human pancreatic cancer.

Authors:  H Kijima; K J Scanlon
Journal:  Mol Biotechnol       Date:  2000-01       Impact factor: 2.695

6.  Apoptosis of human BEL-7402 hepatocellular carcinoma cells released by antisense H-ras DNA--in vitro and in vivo studies.

Authors:  Y Liao; Z Y Tang; K D Liu; S L Ye; Z Huang
Journal:  J Cancer Res Clin Oncol       Date:  1997       Impact factor: 4.553

7.  Use of ribozymes and antisense oligodeoxynucleotides to investigate mechanisms of drug resistance.

Authors:  D Byrne; C Daly; R Nicamhlaoibh; A Howlett; K Scanlon; M Clynes
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058

8.  Ribozyme-mediated inactivation of mutant K-ras oncogene in a colon cancer cell line.

Authors:  T Tokunaga; T Tsuchida; H Kijima; K Okamoto; Y Oshika; N Sawa; Y Ohnishi; H Yamazaki; S Miura; Y Ueyama; M Nakamura
Journal:  Br J Cancer       Date:  2000-09       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.